Barroso-Sousa, R., Zanudo, J. G. T., Li, T., Reddy, S. M., Emens, L. A., Kuntz, T. M., . . . Tolaney, S. M. Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: A phase II trial (NIMBUS). Nature Portfolio.
Chicago Style (17th ed.) CitationBarroso-Sousa, Romualdo, et al. Nivolumab Plus Low-dose Ipilimumab in Hypermutated HER2-negative Metastatic Breast Cancer: A Phase II Trial (NIMBUS). Nature Portfolio.
MLA (9th ed.) CitationBarroso-Sousa, Romualdo, et al. Nivolumab Plus Low-dose Ipilimumab in Hypermutated HER2-negative Metastatic Breast Cancer: A Phase II Trial (NIMBUS). Nature Portfolio.
Warning: These citations may not always be 100% accurate.